<code id='1C3DACA9C7'></code><style id='1C3DACA9C7'></style>
    • <acronym id='1C3DACA9C7'></acronym>
      <center id='1C3DACA9C7'><center id='1C3DACA9C7'><tfoot id='1C3DACA9C7'></tfoot></center><abbr id='1C3DACA9C7'><dir id='1C3DACA9C7'><tfoot id='1C3DACA9C7'></tfoot><noframes id='1C3DACA9C7'>

    • <optgroup id='1C3DACA9C7'><strike id='1C3DACA9C7'><sup id='1C3DACA9C7'></sup></strike><code id='1C3DACA9C7'></code></optgroup>
        1. <b id='1C3DACA9C7'><label id='1C3DACA9C7'><select id='1C3DACA9C7'><dt id='1C3DACA9C7'><span id='1C3DACA9C7'></span></dt></select></label></b><u id='1C3DACA9C7'></u>
          <i id='1C3DACA9C7'><strike id='1C3DACA9C7'><tt id='1C3DACA9C7'><pre id='1C3DACA9C7'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:227
          People in business and medical wardrobe in a table discussion — coverage from STAT
          Adobe

          R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

          Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

          advertisement

          In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Obesity drugs seen as possible treatment for liver disease MASH
          Obesity drugs seen as possible treatment for liver disease MASH

          AdobeAsdrugmakersracetojointheobesitydrugmarketignitedbytheapprovalofWegovyandZepbound,they’renotjus

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          STAT Summit: GSK CEO on pharma giant's new direction

          GSKCEOEmmaWalmsleyatthe2023STATSummit.STATThestoryofGSKisoneofreinvention,CEOEmmaWalmsleysaidattheST